Literature DB >> 22740319

The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.

Keith A Sikora1, Ndate Fall, Sherry Thornton, Alexei A Grom.   

Abstract

OBJECTIVE: Systemic juvenile idiopathic arthritis (JIA) is an autoinflammatory syndrome in which the myelomonocytic lineage appears to play a pivotal role. Inflammatory macrophages are driven by interferon-γ (IFNγ), but studies have failed to demonstrate an IFN- induced gene signature in active systemic JIA. This study sought to characterize the status of an IFN-induced signature within affected tissue and to gauge the integrity of IFN signaling pathways within peripheral monocytes from patients with systemic JIA.
METHODS: Synovial tissue from 12 patients with active systemic JIA and 9 with active extended oligoarticular JIA was assessed by real-time polymerase chain reaction to quantify IFN-induced chemokine gene expression. Peripheral monocytes from 3 patients with inactive systemic JIA receiving anti-interleukin-1β (anti-IL-1β) therapy, 5 patients with active systemic JIA, and 8 healthy controls were incubated with or without IFNγ to gauge changes in gene expression and to measure phosphorylated STAT-1 (pSTAT-1) levels.
RESULTS: IFN-induced chemokine gene expression in synovium was constrained in active systemic JIA compared to the known IFN-mediated extended oligoarticular subtype. In unstimulated peripheral monocytes, IFN-induced gene expression was similar between the groups, except that lower levels of STAT1, MIG, and PIAS were observed in patients with active disease, while higher levels of PIAS1 were observed in patients with inactive disease. Basal pSTAT-1 levels in monocytes tended to be higher in systemic JIA patients compared to healthy controls, with the highest levels seen in those with inactive disease. Upon stimulation of monocytes, the fold increase in gene expression was roughly equal between groups, except for a greater increase in STAT1 in patients with inactive systemic JIA compared to controls, and a greater increase in IRF1 in those with active compared to inactive disease. Upon stimulation, the fold increase in pSTAT-1 was highest in monocytes from patients with inactive systemic JIA.
CONCLUSION: Monocytes in patients with active systemic JIA retain the ability to respond to IFNγ, suggesting that the lack of an IFN-induced gene signature in patients with active disease reflects a limited in vivo exposure to IFNγ. In patients with inactive systemic JIA who received treatment with anti-IL-1β, hyperresponsiveness to IFNγ was observed.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740319      PMCID: PMC3482423          DOI: 10.1002/art.34604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  48 in total

Review 1.  Systemic onset juvenile rheumatoid arthritis.

Authors:  R Schneider; R M Laxer
Journal:  Baillieres Clin Rheumatol       Date:  1998-05

2.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

3.  Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.

Authors:  P Matthys; K Vermeire; T Mitera; H Heremans; S Huang; D Schols; C De Wolf-Peeters; A Billiau
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

4.  Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis.

Authors:  K J Murray; L Luyrink; A A Grom; M H Passo; H Emery; D Witte; D N Glass
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

5.  Inhibition of Stat1-mediated gene activation by PIAS1.

Authors:  B Liu; J Liao; X Rao; S A Kushner; C D Chung; D D Chang; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases.

Authors:  J L Stéphan; J Zeller; P Hubert; C Herbelin; J M Dayer; A M Prieur
Journal:  Clin Exp Rheumatol       Date:  1993 Jul-Aug       Impact factor: 4.473

7.  The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.

Authors:  M M Song; K Shuai
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

8.  Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.

Authors:  An D Billiau; Tania Roskams; Rita Van Damme-Lombaerts; Patrick Matthys; Carine Wouters
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

9.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  21 in total

1.  Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.

Authors:  Grant S Schulert; Mingce Zhang; Ammar Husami; Ndate Fall; Hermine Brunner; Kejian Zhang; Randy Q Cron; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2018-05-02       Impact factor: 10.995

2.  Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans.

Authors:  Shai S Shen-Orr; David Furman; Brian A Kidd; Francois Hadad; Patricia Lovelace; Ying-Wen Huang; Yael Rosenberg-Hasson; Sally Mackey; Fatemeh A Gomari Grisar; Yishai Pickman; Holden T Maecker; Yueh-Hsiu Chien; Cornelia L Dekker; Joseph C Wu; Atul J Butte; Mark M Davis
Journal:  Cell Syst       Date:  2016-10-13       Impact factor: 10.304

3.  Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.

Authors:  Grant S Schulert; Ndate Fall; John B Harley; Nan Shen; Daniel J Lovell; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

Review 4.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

Review 5.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.

Authors:  Adriana Almeida de Jesus; Scott W Canna; Yin Liu; Raphaela Goldbach-Mansky
Journal:  Annu Rev Immunol       Date:  2015-02-20       Impact factor: 28.527

6.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

7.  Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.

Authors:  Scott W Canna; Julia Wrobel; Niansheng Chu; Portia A Kreiger; Michele Paessler; Edward M Behrens
Journal:  Arthritis Rheum       Date:  2013-07

8.  Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.

Authors:  Allison A Throm; Halima Moncrieffe; Amir B Orandi; Jeanette T Pingel; Theresa L Geurs; Hannah L Miller; Allyssa L Daugherty; Olga N Malkova; Daniel J Lovell; Susan D Thompson; Alexei A Grom; Megan A Cooper; Stephen T Oh; Anthony R French
Journal:  JCI Insight       Date:  2018-08-09

Review 9.  Macrophage activation syndrome and cytokine-directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

Review 10.  Macrophage activation syndrome in the era of biologic therapy.

Authors:  Alexei A Grom; AnnaCarin Horne; Fabrizio De Benedetti
Journal:  Nat Rev Rheumatol       Date:  2016-03-24       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.